More articles from 5.1 Airway Pharmacology and Treatment

Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients
Elzbieta Hajol, Annalisa Piccinno, Isabelle Viaud, Isabella Montagna, Alessandro Guasconi, Stefano Vezzoli, Mario Scuri, Mike Polkey

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4065; DOI: 10.1183/13993003.congress-2016.PA4065
Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma
Pradyut Waghray, Mahip Saluja, Mayank Agarwal, Abhijit Vaidya, Jaideep Gogtay, Ashish Kumar Deb, Sneha Limaye, Ashish Goyal, Aloke Gopal Ghoshal, Sudhir Bhatnagar, Akash Balki, George Dsouza, Manish Kumar Jain, Sharad Tikkiwal, Sujeet Rajan, Raja Dhar

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4114; DOI: 10.1183/13993003.congress-2016.PA4114
Evaluation of indacaterol and glycopyrronium as inhalation powder on systemic inflammatory and oxidative stress parameters in severe COPD
Balakrishnan Menon, Charanjeet Kaur, Harsh Vardhan, Mohammad Yusuf Dar

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4098; DOI: 10.1183/13993003.congress-2016.PA4098
A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
L.J. Holmes, D. Ryan, G.A. Tavernier, R.M. Niven

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4101; DOI: 10.1183/13993003.congress-2016.PA4101
Audit of bronchial thermoplasty patients who did not complete their treatment session as planned
K. Hince, L.J. Holmes, G. McCumesky, C. Ustabasi, R.M. Niven, D. Ryan

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4121; DOI: 10.1183/13993003.congress-2016.PA4121
Optimizing patient experience of nebulizer treatments
Ross Hatley, Louise Rowe, Ian Rabbetts, Filippo Quadrelli

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4082; DOI: 10.1183/13993003.congress-2016.PA4082
Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD
Walter Vincken, Antoine Poskin, Sandra Gurdain, Jan Van Schoor, Stefaan Vancayzeele, Paul Van den Brande

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4074; DOI: 10.1183/13993003.congress-2016.PA4074
Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice
Zhenghua Ni, Zhao Li, YiMing Lai, XuMing Luo, Xiongbiao Wang

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4105; DOI: 10.1183/13993003.congress-2016.PA4105
Bronchodilator use in Latin America primary care: The PUMA study
Maria Montes De Oca, Maria Victorina Lopez Varela, Jose Jardim, Roberto Stirvulov, Filip Surmont

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4076; DOI: 10.1183/13993003.congress-2016.PA4076
Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide
Luigino Calzetta, Paola Rogliani, Gabriella Lucà, Maria Gabriella Matera, Mario Cazzola

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4096; DOI: 10.1183/13993003.congress-2016.PA4096

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages